Facility & Capacity

Our 240,000 sq. ft. pharmaceutical factory, built on GSK's foundation, currently produces 11.2 million Vial injections annually. We're expanding the Vial injection line in 2022, set to quadruple capacity to meet international demand.

Top Pharma Outsourcing Company in APAC 2002, awarded by Pharma Tech Outlook.

UBI Pharma Inc. proudly occupies a vast 240,000 square feet pharmaceutical facility. Our state-of-the-art hardware, equipment, and quality systems inherit the legacy of the renowned global pharmaceutical giant, GlaxoSmithKline (GSK), providing us with a rock-solid foundation. Backed by a dedicated team of over 200 research and manufacturing experts, we possess extensive technical expertise and stand ready to embrace commissions from clients worldwide.

Our current Vial injection production line boasts an annual capacity of 11.2 million bottles. In response to the growing demands of the international market, we initiated the expansion of our Vial injection filling line in 2022. Upon activation, this expansion is set to quadruple our production capacity, showcasing our commitment to meeting global needs.